Genetic 'fingerprint' may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds
Women with early-stage breast cancer that has a specific pattern of gene expression are more likely than others to benefit from treatment with a class of common but potentially harmful chemotherapy drugs called anthracyclines, ...
Nov 8, 2019
0
44
